We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.78%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$17.4B
AUM Growth
+$1.04B
(+6.3%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
1,119
New
175
Increased
316
Reduced
445
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$176M |
| 2 |
Airbnb
ABNB
|
+$145M |
| 3 |
Mastercard
MA
|
+$132M |
| 4 |
Edwards Lifesciences
EW
|
+$120M |
| 5 |
Marathon Petroleum
MPC
|
+$92.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$210M |
| 2 |
HCA Healthcare
HCA
|
+$203M |
| 3 |
O'Reilly Automotive
ORLY
|
+$150M |
| 4 |
Expeditors International
EXPD
|
+$91M |
| 5 |
Adobe
ADBE
|
+$78.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.35% |
| 2 | Consumer Discretionary | 13.64% |
| 3 | Healthcare | 12.96% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVRD
501
Tvardi Therapeutics
TVRD
$23.8M
| $2.89M | 0.02% |
+28,413
| New | +$3.91M |
|
502
QCR Holdings
QCRH
$1.65B
| $2.88M | 0.02% |
70,096
-2,103
| -3% | -$86.1K |
|
503
Western Digital
WDC
$172B
| $2.87M | 0.02% |
100,273
-2,394,484
| -96% | -$66.6M |
|
|
DSKE
504
DELISTED
Daseke, Inc. Common Stock
DSKE
| $2.87M | 0.02% |
402,748
+49,408
| +14% | +$347K |
|
505
Pediatrix Medical
MD
$2.15B
| $2.86M | 0.02% |
201,267
+43,626
| +28% | +$613K |
|
|
HRT
506
DELISTED
HireRight Holdings Corporation
HRT
| $2.84M | 0.02% |
251,089
-25,806
| -9% | -$271K |
|
507
Nektar Therapeutics
NKTR
$2.41B
| $2.8M | 0.02% |
324,699
+150,160
| +86% | +$1.6M |
|
508
Stagwell
STGW
$1.92B
| $2.8M | 0.02% |
+387,904
| New | +$2.56M |
|
509
Forestar Group
FOR
$1.47B
| $2.79M | 0.02% |
123,802
+96,019
| +346% | +$1.85M |
|
510
Quanex
NX
$863M
| $2.79M | 0.02% |
103,898
-117,623
| -53% | -$2.62M |
|
511
CytomX Therapeutics
CTMX
$708M
| $2.79M | 0.02% |
1,621,409
-269,977
| -14% | -$448K |
|
512
First Financial Corp
THFF
$924M
| $2.77M | 0.02% |
85,167
+1,306
| +2% | +$44.5K |
|
|
513
Expeditors International
EXPD
$22.4B
| $2.75M | 0.02% |
22,692
-800,610
| -97% | -$91M |
|
514
Wynn Resorts
WYNN
$10.3B
| $2.74M | 0.02% |
+25,952
| New | +$2.78M |
|
515
Brixmor Property Group
BRX
$9.93B
| $2.74M | 0.02% |
+124,572
| New | +$2.6M |
|
516
UiPath
PATH
$6.02B
| $2.74M | 0.02% |
165,305
-33,667
| -17% | -$540K |
|
517
Workiva
WK
$3.13B
| $2.74M | 0.02% |
26,938
+1,800
| +7% | +$173K |
|
518
Range Resources
RRC
$8.85B
| $2.74M | 0.02% |
93,122
+61,378
| +193% | +$1.67M |
|
519
Allegro MicroSystems
ALGM
$8.72B
| $2.7M | 0.02% |
59,916
-50,481
| -46% | -$2.04M |
|
520
Duolingo
DUOL
$6.19B
| $2.7M | 0.02% |
+18,862
| New | +$2.7M |
|
521
FIVE9
FIVN
$1.96B
| $2.69M | 0.02% |
32,669
+493
| +2% | +$33.1K |
|
|
KYNB
522
Kyntra Bio
KYNB
$28.5M
| $2.69M | 0.02% |
39,889
-4,876
| -11% | -$2.02M |
|
523
Centrus Energy
LEU
$3.46B
| $2.66M | 0.02% |
+81,745
| New | +$2.53M |
|
524
Sutro Biopharma
STRO
$398M
| $2.66M | 0.02% |
57,139
-9,321
| -14% | -$464K |
|
525
Conduent
CNDT
$234M
| $2.65M | 0.02% |
+779,680
| New | +$2.55M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2023 Portfolio in Review
As of Q2 2023, Jacobs Levy Equity Management held 1,119 positions worth $17.4B, up 6.3% from $16.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jacobs Levy Equity Management's Q2 2023 filing shows 175 new, 316 increased, 445 reduced and 162 closed positions. Its largest new stake was Airbnb: 1,241,173 shares worth $159M. The largest sale was Netflix, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jacobs Levy Equity Management's largest Q2 2023 buy was Airbnb: 1,241,173 shares worth $159M.
- Jacobs Levy Equity Management added most to Humana in Q2 2023, an estimated $176M increase.
- Jacobs Levy Equity Management's biggest Q2 2023 reduction was Netflix, cutting an estimated $210M.
- Jacobs Levy Equity Management fully exited HCA Healthcare in Q2 2023, selling an estimated $203M.
- Jacobs Levy Equity Management's ten largest holdings make up 21% of its $17.4B portfolio in Q2 2023.
- Jacobs Levy Equity Management opened 175 new positions and closed 162 in Q2 2023.
- Jacobs Levy Equity Management's portfolio value rose 6.3% quarter-over-quarter to $17.4B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2023, filed 14 Aug 2023.